At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,253 enrolled
Drug / intervention
Educationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ADESPI: Adherence to Spiriva® in Patients With COPD, Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice in Central & Eastern European Region
In Brief
An observational study evaluating Education for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 1,253 participants across 90 sites in 3 countries.
Detailed Summary
The objective of this observational study is to collect and evaluate data on medication adherence of patients on maintenance COPD therapy with long-acting anticholinergic (e.g. Spiriva® delivered by HandiHaler® or Respimat®) using the MMAS-8 questionnaire.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesHungary, Slovakia, Slovenia
CollaboratorsPfizer
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 2011
Enrollment StartSep 2011
Primary CompletionDec 2013
TodayJul 2026
First PostedJul 6, 2011
Enrollment StartSep 1, 2011
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 15.0 years ago
Interventions
Educationprocedure
Education